Cargando…

Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection()()

Detalles Bibliográficos
Autores principales:	O'Moráin, N, Stack, R, Doherty, J, Tosetto, M, Garcia Leon, A, Mallon, P, Doherty, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233623/ https://www.ncbi.nlm.nih.gov/pubmed/35768051 http://dx.doi.org/10.1016/j.jinf.2022.06.016

Ejemplares similares

Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION)
por: Doherty, Jayne, et al.
Publicado: (2022)

Dynamics of faecal SARS-CoV-2 in infected children during the convalescent phase
por: Xing, Yuhan, et al.
Publicado: (2020)

A stalk with no polyp—A muco‐submucosal elongated polyp in the duodenum
por: O’Morain, Neil, et al.
Publicado: (2023)

Hemorrhagic stroke in hispanics with severe SARS-CoV2 infection
por: Castillo, P.R., et al.
Publicado: (2020)

Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine
por: Carli, Giuseppe, et al.
Publicado: (2021)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP()
por: Zúñiga, José, et al.
Publicado: (2021)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Myopathy associated with severe SARS-CoV-2 infection
por: Abenza Abildúa, M.J., et al.
Publicado: (2020)

A meta-analysis of the association between calprotectin and the severity of COVID-19
por: Mao, Qin, et al.
Publicado: (2022)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
por: Bojkova, Denisa, et al.
Publicado: (2022)

Faecal calprotectin concentration in children with coeliac disease
por: Szaflarska-Popławska, Anna, et al.
Publicado: (2020)

Guidance on the interpretation of faecal calprotectin levels in children
por: Orfei, Martina, et al.
Publicado: (2021)

Giardiasis reactivation during severe SARS-CoV-2 infection
por: Lupia, Tommaso, et al.
Publicado: (2021)

Transient severe neutropenia in an infant with SARS-CoV-2 infection
por: Irie, Shinji, et al.
Publicado: (2022)

Living evidence for SARS-CoV-2()
por: Santillan-Garcia, A.
Publicado: (2021)

Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients
por: Mentzer, Alexander J, et al.
Publicado: (2022)

SARS CoV-2 seropositivity in haemodialysis patients
por: Toapanta, Nestor, et al.
Publicado: (2022)

Implementation of BSG/ACPGBI/PHE polypectomy surveillance guidelines safely reduces the burden of surveillance in a screening cohort: a virtual model study
por: Stack, Roisin, et al.
Publicado: (2023)

SARS-CoV-2 and EBV coinfection()
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)

SARS-CoV-2: Is the liver merely a bystander to severe disease?
por: Bangash, Mansoor N., et al.
Publicado: (2020)

Altered severity of the current SARS-CoV-2 in the Kurdistan region of Iraq
por: Hussein, Safin, et al.
Publicado: (2020)

SARS-CoV-2 Infection in a Child with Severe Congenital Neutropenia
por: Vignesh, Pandiarajan, et al.
Publicado: (2021)

Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection()
por: Figuero-Pérez, Luis, et al.
Publicado: (2023)

Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals
por: Allen, Niamh, et al.
Publicado: (2021)

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
por: Szymańska, Edyta, et al.
Publicado: (2020)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

Faecal calprotectin indicates intestinal inflammation in COVID-19
por: Effenberger, Maria, et al.
Publicado: (2020)

Gastrointestinal manifestations and their relation to faecal calprotectin in children with autism
por: Azouz, Hanan Galal, et al.
Publicado: (2021)

Faecal calprotectin in COVID-19 patients with intestinal symptoms
por: Ellakany, Walid Ismail, et al.
Publicado: (2022)

Outcome of patients receiving V-V ECMO for SARS-CoV-2 severe acute respiratory failure
por: Morris, I.S., et al.
Publicado: (2023)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

False positives in SARS-CoV-2 disease()
por: Pardo-Lledias, Javier, et al.
Publicado: (2021)

Comparison of a rapid test and an automated method for faecal calprotectin measurement
por: Martins, Sandra, et al.
Publicado: (2019)

Is there a bidirectional interaction between periodontitis and the severity of SARS-CoV-2 infection?
por: Andrade, Rayle Monteiro, et al.
Publicado: (2021)

SARS-CoV-2 Omicron infection, who will be developed into severe/critical diseases?
por: Feng, Mudan, et al.
Publicado: (2023)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Preliminary data on severe SARS-CoV-2 infection caused by the 501Y.V2 variant
por: Louis, Guillaume, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_juf8o56jkabtnnmspr340ai5a2